MENU
GKOS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Glaukos (GKOS) Earnings Date & Reports

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

A.I. Advisor
published Earnings

GKOS is expected to report earnings to rise 24.23% to -27 cents per share on July 30

Glaukos GKOS Stock Earnings Reports
Q2'25
Est.
$-0.27
Q1'25
Beat
by $0.13
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.20
Q2'24
Est.
$-0.52
The last earnings report on April 30 showed earnings per share of -21 cents, beating the estimate of -34 cents. With 773.10K shares outstanding, the current market capitalization sits at 4.61B.
View a ticker or compare two or three
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com